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1. Introduction 
Activation of the classical pathway of the com- 
plement system 1s brought about by the bmding of the 
first component of complement, Cl, to antibody- 
antigen complexes. Cl is a glycoprotein complex, 
contaming 3 types of subumts, Clq, Clr and Cls, of 
which the two latter are se&e protease zymogens 
[l]. The interaction of Clq with antibody in immune 
complexes leads to the sequential ctivation of Clr 
and Cls by hmlted proteolysls [2]. The proteases Cir 
and Cis are both of mol. wt 83 000, and have struc- 
tures sirmlar to that of plasmm [3]. As with other 
plasma proteases, the actlvitles of Cir and Cis are 
regulated by protease inhibitors. In plasma there are 
7 well-characterised protease inhibitors, each capable 
of mhlbitmg several serine proteases [7,8]. AdditIonal 
plasma serine protease mhbitors have been described 
[7]. Although Cir and Cis are both known to form 
stable complexes urlth Cilnhlbitor (Ci In) [4,5], httle 
information is available on their activity towards 
other protease mhibltors. A simple, and widely 
applicable techniqu_e, involvmg incubation of “‘I- 
labelled Cir and Cls ~th plasma, followed by gel 
filtration, affinity chromatography and SDS-poly- 
acrylamide gel analyses has been used to mvestlgate 
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the interaction of Cir and Cis with mhlbitors in 
whole plasma. The results demonstrate, consistent 
v&h the very restricted proteolytlc specificity of Cir 
and Cis, that CT In 1s the only physiological mtibi- 
tor of both proteases. The iodmation procedure used 
does not detectably alter any of the activities of the 
two enzymes. 
2. Materials and methods 
2.1. Proteins 
Human cltrated plasma was obtained from the 
Centre de Transfusion Sanguine, Grenoble. Preparation 
of serum [9] and the isolation of Ci In [4], Cir and 
Cis [ 1 ,101 were as previously described. Purified 
proteins were quantified from their specific A 2~, 
using $b = 4.5, 11.5 and 9.4, respectively, for Ci 
In, Clr and Cls [3,11]. 
2.2. Anti-CT in antibody linked to Sepharose 6B 
The total lmmunoglobuhn fraction was precipitated 
from 5 ml rabbit ant1 CT In antiserum (Behrmg) and 
coupled to 10 ml (packed volume) of cyanogen 
bromide-activated Sepharose 6B. Coupling yield was 
70%. Procedures were as in [ 121. 
2.3. Iodina tion 
Iodinatlon of C& and Cis was done by a mo&fica- 
tion of the Cl q-labelling method m [ 131. Solutions of 
Cis (500 I.cg/ml) or Cir (250 pg/ml) m 5 mM 
triethanolamme-HCl, 145 mM NaCl (pH 7.4) were 
chdled to O”C, and the following quantities of 
reagents, made up in the same buffer, were added per 
111 
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1 ml protem solution 50 ~120 PM NaI, 50 ~1 Nali51 
(Amen&am) adjusted to spec. act. 0.5 &r/ml, 50 1.11 
2 mg/ml actoperoxidase (Calbiochem, Grade B) and 
20 ~.cl l/20 000 drlution of 30% HzOZ. After 50 min 
incubation at O”C, free “‘1 was removed from the 
mixture by gel filtration on a column (25 X 1 cm) 
of Sephadex G-50 in 5 mM triethanolamine - HCl, 
145 mM NaCl, 0.02% w/v NaNs (pH 7.4). The 
labelled protein was pooled, dialysed against 1 1 of 
the gel filtration buffer, and stored at 4°C. 12’1 was 
counted on an Intertechmque CG 2000 gamma 
counter. The activities of the labelled proteins were 
verified m the following functronal tests Cis a-N- 
benzyloxycarbonyl-Llysine p-nitrophenol esterase 
activity [3], Cir acetyl arginine methyl esterase 
activity [ 141, capacity of Cir to activate proenzymrc 
Cis [3]; subcomponent Cir and Cis haemolytic 
acticty [9], and the specific and sequential binding 
of Clr then Cis to antibody-antigen-Cl q complexes 
[2,15]. In additron, the rates of reaction of labelled 
and unlabelled Cir and Cis with CT In were com- 
pared (see fig.1). 
2.4. Protease-protease inhibltor Interactians 
The interaction of Cir of Cis with protease mhibi- 
tors was studied by adding 25 pg or 250 pg Cir or 
Cis, containing in eachcase 2X 10’ cpm 12SI-labelled 
material, to 500 /.d titrated plasma or to 500 fl 
serum in the presence of 5 mM CaC12 or 5 mM EDTA. 
The two concentrations of labelled protease used 
were chosen to be respectively ess than, and greater 
than, the total inhibitory capacity of CT In in plasma. 
Soybean trypsin mhrbitor (1 mg/ml) 100 d was 
added to hmit proteolysis by other proteases present 
m plasma. Control experiments were performed m 
which 500 @ 5 mM trlethanolamin~--HCl, 145 mM 
NaCl (pH 6.4) containing 150 E.cg Cl In + 15 mg BSA 
was used instead of plasma. Samples were incubated 
1 h, 37”C, and the size distribution of the labelled 
species m each sample was then examined by gel 
filtration on Ultrogel AcA-34. All eluate fractions 
containing radioactivrty were pooled and passed 
through a column of anti-Ci In antibody lmked to 
SepharosedB. Radroactive material not binding to 
thrs column was pooled, concentrated to 1 ml by 
ultrafiltration, and the remaining labelled species 
were reexamined on the Ultrogel AcA-34 column. 
Peaks of radioactivity eluted from Ultrogel were 
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pooled individually, concentrated to a small volume, 
and their composition was analysed by SDS-poly- 
acrylamide gel electrophoresis. Material bound to the 
ant& In column was eluted with 1 M NH+SCN, 
dialysed against the chromatography buffer, and 
examined on SDS-polyacrylamide gels. 
Preparation of samples for SDS-polyacrylamide 
gel electrophoresis, the electrophoresrs system, and 
gel stammg were as in [3]. Gels stained wrth Coomassie 
blue were scanned [ 121 and cut into 2 mm slices for 
“‘1 counting. 
Determination of hydrodynamic parameters by 
sucrose density gradient centrifugauon and gel filtra- 
tion was as in [3]. 
3. Results and discussion 
3.1, Zodim tion 
Iodination of Cir and Cis resulted m 35-40% 
cir - 
T1llle 
Frg 1 Comparison of the rates of reactron of rodmated and 
non-rodlnated Cir and 6s wrtb CT In. “‘1-1abelled Cir or 
Cis were diluted with cold Cir or Cis such that the overall 
labelhng represented 5 atoms I/l00 molecules Cir or Cis. 
The Cir (450 pg/ml) or Cis (440 ng/ml) m 5 mM trrethanol- 
amine-HCl, 145 mM NaCI, 5 mM EDTA (pH 7 4) was then 
incubated with CT In (920 ng/ml) at 37’C Reactron was 
stopped at various times by placing 50 r.11 of the reaction 
mrxture m 50 r.d 0 2 M Tris-HCl, 8 M urea, 2% w/v SDS, 
40 mM rodoacetamide (pH 8 0) and incubating 4 min at 
1OO’C Samples were then exammed on SDS-polyacrylamrde 
gels, and the gels stained and scanned The rate of uptake of 
total (i,e., labelled + u&belled cir or Cis into complexes 
with Cl In (e) was estimated from the decrease m mtensrty 
of the free Cir or C’is peaks on the gels Gels were then sliced 
and the rate of complexatron of labelled Cir or Cis wrth Ci 
In (0) calculated from the radroactivrty associated with the 
free protease and Cl In-protease complex bands 
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mcorporation of the total radioactivity supplied for 
Cir, and 404.5% for Cis, correspondmg to final 
spec. act. 2.9-3.3 @&no1 for Cir and 1.7-l .9 
&r/nmol for Us. In Cir, 66-70% of the total 
labelling 1s m the light (B) polypeptide cham, 
while for Cis, 93-95% 1s m the heavy (A) chain. 
None of the bindmg or enzymic activities of Cir 
or Cis was detectably altered by rod&ration. The rate 
of mteraction of the labelled proteases with Ci m 
(fig.1) was rdentrcal to the rate observed wrth total 
(i.e., labelled + unlabelled) material showmg that 
iodmation is again without affect on this activrty. 
It has been shown [ 161 that iodinatron of Cis may 
lead to loss of reactrvrty with Ci In, and posnbly to 
altered capacity to interact with other Cl subcom- 
ponents. The todination procedure described above 
is, however, done with considerably ower quantrtres 
of oxidrsmg agent han m [ 161. 
The same lodmatlon procedure is app~cable to
proenzymrc Clr and Cl s, wrth which similar odma- 
tron yrelds are obtained. 
3.2. ~otea~e-p~otea~e ~~~i~itor tnte~actions 
All of the well-charactensed plasma protease 
mhibrtors (or antrtrypsm, 0~2 macroglobulm, Ci In, 
inter-o-trypsm inhibrtor, LYZ antrplasmm, antrchymo- 
trypsm and ~~~rombin III) n&bit proteases by 
forming complexes with them [6,7]. These complexes 
are stable during gel filtration, and also (wrth the 
exceptron of (~2 macro~ob~ln-protease complexes) 
durmg SDS-polyacrylamrde gel electrophoreas. 
Incubatron of ‘251-labelled Cir or C& with plasma, 
followed by gel filtration demonstrates (fig.2) that 
Cir and Cis are taken up mto complexes of h&er 
molecular werght durmg incubation. In this gel 
filtration system free Cis behaves as an 83 000 mol. 
wt monomer whrle CL 1s a 166 000 mol. wt drmer 
[3 1. Wrth ad~tions of 25 c1g Cir or Cis to plasma, 
nearly all of each protease becomes compIexed 
(fig.2b,d) whrle with 250 ng additions much of the 
Cir and Cis added does not form higher molecular 
weight complexes. Elutron profiles of radioactivity 
from samples incubated with plasma, with serum m 
the presence of Ca2’ or EDTA, or control samples 
incubated with CT m were all very srmrlar. 
Passage of the pool of raQoactrve fractions from 
Ultrogel through the column of antiCi In resulted 
111 retention of a percentage of the radxoactrvity 
Volume eluted (ml ) 
Fig 2. First gel fAtration analysis of complex formation 
Samples were run on a column (48 X 1 cm) of UItrogel AcA 
34 in 5 mM triethanoIamine-HCl, 145 mM NaCI, 5 mM 
EDTA The elutron profde of radroactrvity (-•-) and 
of&, (---) shown for s_amples of proteases mcubated_< 
with plasma,(A) 250 gg Clr, (B) 25 #Fig Clr, (C) 250 ggCls, 
@) 25 pg Cls. The ehrtron positrons of free labelled Cl r and 
Cls, run as standards, are shown by arrows. V, = vord 
volume. 
Table 1 
Percentage retention of ‘2SI-labelled Cir or “WabeBed 
Cls on Sepharose-anti Cl In 
Sample % Radioactivity 
retamed 
cir ( 25 wg) + plasma 72 
Cir ( 25 pg) + CT In + BSA 77 
cis ( 25 pg) f plasma 82 
Cis ( 25 pg) + Ci In + BSA 85 
Cir (250 rg) + plasma 26 
cir (250 pg) + ci In + BSA 29 
Cis (250 clg) + plasma 31 
cis (250 rg) + ci In + BSA 35 
113 
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(table 1) which corresponds closely to the % “‘I- 
labelled protease taken up into higher mol. wt com- 
plexes (as seen m fig.2). The specificity of the affinity 
column for the retention only of material bound to 
CT In was confirmed by showmg that all radroactlve 
material retained on this column, when exammed on 
SDS-polyacrylamide gels, behaved as Cir-Ci In, or 
as appropriate, Cis-Ci In complexes (c f. fig.3). The 
molecular weight of CT In is sufficiently distinct from 
those of other well-characteristed protease mhrbrtors 
that simple analysis by SDS-polyacrylamide gel 
electrophoresis 1 adequate to identify complexes of 
CT In with a known protease. The mobihtres of com- 
plexes of Cir and CT’s with Ci In m this electro- 





I I I I I I 1 , 
145 105 75 35 25 
MOL. ‘NT .:;-3 
Frg.3 Pattern of migratron of ‘251-labelled polypeptrde chants 
of Cir, Cis and thetr complexes with d In on SDS-poly- 
acrylamide gels. 15 000-18 000 cpm was loaded onto each 
gel Alkylated samples (-•-) and reduced and 
alkylated samples (--o--) areshovjn (A) Cis, (B) Cir, 
(C) Cis-Ci In complex, (D) Clr-Cl In complex The 
molecular weight scale refers only to reduced samples CisA, 
C&A and CisB, C&B A cham of Cir, Cis and B chain of 
cir, cis, respectively. 
0 10 20 
Vol eluted (ml ) 
30 
Fig.4 Second gel filtration analysis radioactive material not 
retamed on Sepharose 6B-anti CT In The elutlon profile of 
radroactrvity is shown. Conditions, and rdentrticatron of 
samples as in fig.2 
Re-exammatron Ultrogel AcA 34 of the 
remaining radroactrve material which drd not bmd to 
the affinity column showed (fig.4) that all of thus 
material behaved as free Cir or Cis. This was con- 
firmed by subsequent analysrs on SDS polyacrylamrde 
gels (c.f. fig.3). In some experiments, up to 10% of 
the remaming free Cir was seen to have undergone a
proteolytrc degradatron similar to that m [ 171. 
These results demonstrate hat CT In is the only 
protease mlvbrtor in plasma or serum which forms a 
stable complex with Cir or Cis. Incubation of 25 l.(g 
additrons of these proteases, which do not exceed 
the inhibitory capacity of Cl In m plasma, result m 
uptake of most of the protease mto higher molecular 
weight complexes. When the addition of protease 
exceeds the capacity of CT In, however, much of the 
added protease remams m the free state. All higher 
molecular werght complexes formed were removed by 
114 
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chromatography on anti-Ci In, leavmg only free Cir 
and Cis. Smce in these experiments recovery of radlo- 
activity at each step was X5%, non-specific loss of 
other protease-protease inhibitor complexes 1s 
unlikely to influence the results. The method used 
here, gel filtration before and after affinity 
chromatography usmg antibody against the principal 
known mhibltor, is generally applicable as a means to 
simplify systems where several proteases and inhibitors 
may be mvolved. 
CT In is hkely therefore to be the prmapal 
m~bltor of Cir and Cis m vivo, although cellular 
protease inhibitors may also be involved. Evidence has 
been presented [ 181 that Ci In is the major in vlvo control 
of Cis. Cis has also been reported to be inhibited by 
very h@ concentrations of heparin and antithrombm 
III [ 191. The experiments described above, however, 
were done in heparin-free conditions. The result 
obtamed here confirms observations that Cir is not 
tibited by (Y~ macroglobulm, inter-a-trypsm_ . 
inhibitor and CQ antltrypsin [20]. Similarly, Cls has 
been reported to be unreactive towards (Y~ antltrypsm 
[ 191 and (~2 antiplasmin [21]. Thus Cir and Cis, 
unlike the many other plasma proteases are inhibited 
by only one of the plasma tibitors. Thu is com- 
patible with the very restricted proteolytic specificity 
of these two enzymes [3,9]. 
An anomaly m the behaviour of Cir was also noted 
m these expenments. Since Cir 1s a dimer [3] it may 
be expected to form complexes contalmng either one 
or two molecules of ci In. The Cir dimer dissociates 
on SDS-polyacrylamlde gel electrophoresis, and thus 
complexes of type Cir, -CT InI should dissociate 
mto free Cir plus Cir, -CT In1 complexes in SDS. 
Analysis on SDS-polyacrylamlde gels of material 
retamed on the affinity column after mcubatlon of 
excess Cir (250 pg) with plasma, showed only Cir, - 
CT In1 complexes, and no free Cir. Thus m condi- 
tions where Cir 1s m excess of Ci In, whch should 
favour formation of Cir, -ci In1, ttis type of com- 
plex was not detected. Sucrose density gradlent and 
gel filtration analysis of mixtures of excess Cir t ci 
In also suggest that only complexes of the type 
Cir2 -CT In2 are formed. Tlus result may indicate 
cooperativlty m the reaction of Cir with CT In. The 
techniques presently avadable for investigating the 
kmetlcs of tis reaction (as seen in fig.1 b) are not 
suffclently rapid to confirm this possibility. 
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